Work

BrECADD vs BEACOPP and Health-Related Quality of Life in Advanced-Stage Hodgkin Lymphoma

Year: 2026

Type: article

Abstract: This secondary analysis of the GHSG HD21 randomized clinical trial evaluates the tolerability and impact of BrECADD vs escalated BEACOPP on health-related quality of life for patients with Hodgkin lymphoma.

Source: JAMA Oncology

DOI: 10.1001/jamaoncol.2025.6327

Authors: Justin Ferdinandus, Horst Müller, Janina Jablonski, Andrea Kerkhoff, Sebastian Scholl, Yon-Dschun Ko, Max S. Topp, Vladan Vucinic, Wolfram Jung, Roland Schroers, Andreas Rank, Michael Fuchs, Gundolf Schneider, Volker Diehl, Peter Borchmann, Karolin Behringer

Institutions: University of Cologne, University Hospital Cologne, University of Münster, University Hospital Münster, Jena University Hospital, Johanniter-Krankenhaus Bonn, University of Würzburg, Universitätsklinikum Würzburg, Leipzig University, Universitätsmedizin Göttingen, University of Göttingen, Universitätsklinikum Knappschaftskrankenhaus Bochum, University Hospital Augsburg

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7127900008

FWCI: 9.109

Cites: 6

Cited by: 2

Related to: